RevMed RMC-6236-304
Medical
Free
Revolution Medicines RASolute 304 Clinical Assessments. App is intended to collect patient reported outcomes relating to the RASolute 304 (RMC-6236-304) clinical trial
Revolution Medicines RASolute 304 Clinical Assessments App is intended to collect patient reported outcomes relating to the RASolute 304 (RMC-6236-304) clinical trial. Patients must be given accounts by a participating site in order to log in to the app.
Ratings & Reviews
- This app hasn’t received enough ratings or reviews to display an overview.
This update from Apple will improve the functionality of this app. No new features are included.
Language Release
The developer, ERT,INC, indicated that the app’s privacy practices may include handling of data as described below. For more information, see the developer’s privacy policy .
Data Not Linked to You
The following data may be collected but it is not linked to your identity:
- Health & Fitness
Accessibility
The developer has not yet indicated which accessibility features this app supports. Learn More
Information
- Seller
- ERT, INC
- Size
- 89.7 MB
- Category
- Medical
- Compatibility
Requires iOS 12.0 or later.
- iPhone
Requires iOS 12.0 or later. - iPad
Requires iPadOS 12.0 or later. - iPod touch
Requires iOS 12.0 or later. - Apple Vision
Requires visionOS 1.0 or later.
- iPhone
- Languages
- English
- Age Rating
13+
- 13+
- Infrequent
Medical Treatment information
Contains
Health or Wellness Topics
- Copyright
- © 2025 Clario